中国中西医结合外科杂志2024,Vol.30Issue(1) :38-43.DOI:10.3969/j.issn.1007-6948.2024.01.008

骨科Ⅰ号合剂联合利伐沙班对股骨粗隆间骨折术后患肢肿胀及下肢静脉血栓的临床效果

Clinical observation of orthopedics No.Ⅰ heji combined with rivaroxaban tablets in the treatment of limb swelling and lower limb venous thrombosis after intertrochanteric fracture of femur

张飞 刘俊 杨晓建
中国中西医结合外科杂志2024,Vol.30Issue(1) :38-43.DOI:10.3969/j.issn.1007-6948.2024.01.008

骨科Ⅰ号合剂联合利伐沙班对股骨粗隆间骨折术后患肢肿胀及下肢静脉血栓的临床效果

Clinical observation of orthopedics No.Ⅰ heji combined with rivaroxaban tablets in the treatment of limb swelling and lower limb venous thrombosis after intertrochanteric fracture of femur

张飞 1刘俊 1杨晓建1
扫码查看

作者信息

  • 1. 如皋市中医医院骨伤科(如皋 226500)
  • 折叠

摘要

目的:探讨骨科Ⅰ号合剂联合利伐沙班对股骨粗隆间骨折术后患肢肿胀及下肢静脉血栓的临床效果.方法:选择2020年1月—2022年5月我院收治的股骨粗隆间骨折术后下肢静脉血栓患者72例,根据随机数字表法分为观察组与对照组各36例.对照组给予利伐沙班治疗,观察组在对照组基础上给予骨科Ⅰ号合剂治疗.观察并比较两组治疗前后临床疗效,血栓弹力图指标[凝血反应时间(R)、凝血形成时间(K)、凝固角(α)、血栓最大强度(MA)和综合凝血指数(CI)],凝血指标[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、凝血酶时间(TT)、D-二聚体],下肢静脉彩超结果(双侧股静脉血流速度),患肢肿胀程度(膝关节周径、髌骨上10 cm周径、髌骨下10 cm周径)及治疗后下肢静脉血栓发生率.结果:治疗后观察组总有效率为94.44%,显著高于对照组75.00%(P<0.05);治疗后两组血栓弹力图指标R、K值均较治疗前升高,α、MA、CI值均较治疗前降低,且观察组优于对照组(P<0.05);治疗后两组血凝指标PT、APTT、TT值均较治疗前升高,FIB、D-二聚体值均较治疗前降低,且观察组优于对照组(P<0.05).治疗后两组下肢股静脉血流速度均较治疗前增快,且观察组优于对照组(P<0.05).治疗后两组患者膝关节、髌骨上10cm周径、髌骨下10 cm周径均较治疗前降低,且观察组低于对照组(P<0.05).治疗2个月后,观察组下肢静脉血栓发生率为13.89%,显著低于对照组的38.89%(P<0.05).结论:骨科Ⅰ号合剂联合利伐沙班可有效降低股骨粗隆间骨折术后患肢肿胀程度,减少下肢静脉血栓形成,提高下肢静脉血流速度,改善凝血及血栓弹力图指标,临床疗效显著.

Abstract

Objective To investigate the clinical observation of orthopedics No.Ⅰ heji combined with rivaroxaban in the treatment of limb swelling and lower limb venous thrombosis after intertrochanteric fracture of femur.Methods A total of 72 patients with lower extremity venous thrombosis after intertrochanteric fracture in our hospital were selected,and divided into observation group and control group with 36 patients in each group.36 patients in control group were treated with rivaroxaban tablets,and observation group was treated with orthopedic No.Ⅰ heji on the basis of control group.The clinical efficacy,thromboelasticity chart indexes(coagulation response time(R),coagulation formation time(K),coagulation Angle(α),maximum thrombotic intensity(MA)and comprehensive coagulation index(CI))of the two groups before and after treatment were observed.Coagulation indicators(PT),activated partial thrombin time(APTT),plasma fibrinogen(FIB),thrombin time(TT),D-dimer,color ultrasound results of lower limb veins(bilateral femoral vein blood flow velocity),swelling degree of affected limb(circumference of knee joint,10 cm above patella,10 cm below patella).Results After treatment,observation group total effective rate was 94.44%,higher than that of control group 75%(P<0.05).After treatment,the values of thrombus elasticity chart R and K were higher than before treatment,and the values of α,MA and CI were lower than before treatment(P<0.05).the values of coagulation index PT,APTT and TT were higher than those before treatment,and the values of FIB and D-dimer were lower than those before treatment(P<0.05).the blood flow velocity of limb femoral vein in both groups was faster than that before treatment(P<0.05).knee joint,the 10 cm circumferential diameter above patella and the 10 cm circumferential diameter below patella were all decreased in 2 groups compared with before treatment.All of these project the observation group was better han the control group(P<0.05).Conclusion The combination of orthopedics No.Ⅰ heji and rivaroxaban can effectively reduce the degree of swelling of the affected limb after the operation of intertrochanteric fracture of femur,reduce the formation of lower limb venous thrombosis,improve the velocity of lower limb venous blood flow,and improve coagulation and thromboelasticity index,with significant clinical efficacy.

关键词

骨科Ⅰ号合剂/利伐沙班/股骨粗隆间骨折术后/患肢肿胀程度/下肢静脉血栓

Key words

Orthopedics No.Ⅰ heji/rivaroxaban/postoperative operation of intertrochanteric fracture of femur/the degree of swelling of the affected limb/lower limb venous thrombosis

引用本文复制引用

基金项目

2021年度南通市基础研究和民生科技计划指导性项目(JCZ21102)

出版年

2024
中国中西医结合外科杂志
中国中西医结合学会 天津市中西医结合急腹症研究所

中国中西医结合外科杂志

CSTPCD
影响因子:0.918
ISSN:1007-6948
参考文献量23
段落导航相关论文